TuesdayDec 01, 2020 10:29 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Upcoming Acclaim-1 Clinical Trial

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, on Monday announced its commencement of clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small cell lung cancer (“NSCLC”). The company’s timing of patient recruitment and enrollment keeps it on track for its Acclaim-1 clinical trial to commence in the first-half of 2021. “Our clinical team is engaging with prestigious cancer centers and research institutions across the U.S. to ensure we select optimal study sites, which play an important role in the success of a clinical trial,” said Rodney Varner,…

Continue Reading

TuesdayDec 01, 2020 9:00 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine

VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled the early research and development of VistaGen's PH94B and PH10. The two intranasal neuroactive steroid drug candidates (pherines) have potential for the rapid-onset treatment of anxiety and depression disorders, respectively. VistaGen is a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Throughout…

Continue Reading

MondayNov 30, 2020 3:46 pm

Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Focused on Readily Developable Copper-Gold Project as Demand Rises

Demand for copper is rising; deficit forecast in coming years Copper deficit heightens need for projects that can produce the high-demand metal Feasibility study concluded that Josemaria’s average annual metal production of 136,000 tonnes of copper (“Cu”), 231,000 ounces of gold (“AU”), 1,164, 000 ounces of silver (“Ag”) Strategic plan demonstrates commercial production at project could be achieved by early 2026 The looming copper deficit will likely worsen in the coming years, according to an S&P Global Market Intelligence report (https://ibn.fm/OSonS). That news is capturing the attention of companies such as Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF), a Canadian natural…

Continue Reading

MondayNov 30, 2020 3:23 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Agreement for Expansion into EU Market

Brain Scientific’s (OTCQB: BRSF) Vice President of Marketing, Stuart Bernstein, has written an article for Health Care Business News titled, “COVID's influence on neurology drives need for disposable technologies.” The piece discusses increased concern for health care and frontline workers treating emergent cases for COVID-19 patients developing neurological symptoms and conditions, as well as a critical need for testing solutions. The article reads, “Sudden onset of seizures, metabolic encephalopathy, stroke and other neurological conditions can negatively impact COVID patient outcomes and morbidity rates. Growing evidence of the commonality of neurological symptoms in COVID patients, coupled with challenges in accessibility, efficiency…

Continue Reading

MondayNov 30, 2020 3:04 pm

QualityStocksNewsBreaks – Appreciated Media Holdings Inc. (TSXV: AMH) (OTCQB: AMEFF) Announces Changes to Management, Board Structure, Enters into Forbearance Agreement

Appreciated Media Holdings (TSXV: AMH) (OTCQB: AMEFF) on Thursday announced the resignation of Douglass Magallon and Gregory Strom as directors of the corporation effective Nov. 13, 2020, as well as expiry of the forbearance period granted pursuant to the forbearance agreement, as amended and supplemented, between the corporation and Amcomri GP BVI Limited, previously disclosed Aug. 17, 2020. In addition, Appreciated Media on Friday announced that its board of directors has negotiated a forbearance agreement with Amcomri GP BVI Limited until January 5, 2020. As a condition to the receipt of forbearance, the board has approved a reorganization of the…

Continue Reading

MondayNov 30, 2020 2:46 pm

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Preclinical Data for Potential Anxiety Treatment

VTGN CEO “even more excited about PH94B's potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B's mechanism of action may not have benzodiazepine-like side effects, such as sedation, cognitive impairment or abuse liability Company making significant progress in preparing PH94B for launch of pivotal Phase 3 study for acute treatment of anxiety in adults with social anxiety disorder VistaGen Therapeutics (NASDAQ: VTGN) has reported new preclinical findings differentiating the mechanism of action of PH94B from that of benzodiazepines (https://ibn.fm/Al4ur). PH94B is an intranasal neuroactive steroid VistaGen is preparing for Phase 3 development…

Continue Reading

MondayNov 30, 2020 2:23 pm

As World Transitions away from Gas Guzzlers, Net Element Inc. (NASDAQ: NETE) Entering EV Market Through Mullen Technologies Merger

NETE plans to divest payments processing model to enter EV industry through proposed merger with privately-held Mullen Technologies Inc. Merger allows Mullen stakeholders to obtain majority of stock while accelerating process of taking company public, funding US expansion Mullen accepting reservations for Dragonfly K50 sports car and MX-05 SUV, production for both projected to start in 2021 California-based Mullen subsidiaries include Mullen Energy, Mullen Auto Sales, Mullen Finance Corp., CarHub digital marketplace Future generations may look back and wonder how humanity withstood the exhaust fumes, noise and environmental degradation created by fossil fuel engines. The downsides of combustible engines, rising…

Continue Reading

MondayNov 30, 2020 2:04 pm

Amid Pandemic’s Battering on Hemp / CBD Markets, HempFusion Wellness Inc. Sees Brighter Future

Denver-based HempFusion Wellness, Inc. has developed 46 products and 8 OTC FDA listed topicals that draw on the versatile compounds in hemp for promoting effective sleep, stress reduction, pain relief, skin care and “smooth energy” pick-me-ups Despite a downturn in the hemp and CBD product industries brought on by the worldwide COVID-19 pandemic, HempFusion is anticipating a market rebound amid positive developments in legal, political and medical research arenas Market analysts at Brightfield Group anticipate improvement in the CBD sector to $12.4 billion by 2023 and $16.8 billion by 2025 HempFusion has filed a preliminary prospectus for a planned initial…

Continue Reading

MondayNov 30, 2020 1:35 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Featured in SNN Network Interview

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap News Source(TM).” According to the update, Jupiter Wellness CEO Brian John and chairman and Chief Scientific Officer Dr. Glynn Wilson joined SNN host Robert Kraft to discuss the company’s focus on proprietary patent/patent-pending CBD sun and skin care brands. “We wanted to focus this company on our own proprietary patented or patent-pending products, and that’s really what Jupiter Wellness was built around. We have four…

Continue Reading

MondayNov 30, 2020 1:19 pm

Emerging Functional Mushroom Market Ripe with Potential for Rritual Superfoods’ New Product Line

Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarity Market analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the trend Rritual was recently certified by the USDA as an organic product, providing third-party validation Rritual’s quality protocols Rritual’s initial product launch includes elixirs containing mushroom and adaptogenic herb blends such as Chaga-Eleuthero, Lion’s…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered